During the past decade, SC Oncolab SRL conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SC Oncolab SRL" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SC Oncolab SRL" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "SC Oncolab SRL" are "Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Advanced or Inoperable Gastric Cancer" (1 trials). Many other conditions were trialed in "SC Oncolab SRL" in a lesser frequency.

Most popular intervention types in "SC Oncolab SRL" are "Drug" (22 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (4 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "SC Oncolab SRL" are 16 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "SC Oncolab SRL". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in SC Oncolab SRL, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SC Oncolab SRL, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".